Similarly, MBNL1-AS1 inhibited proliferation of bladder cancer through MBNL1-AS1/MiR-362-5p/QKI and MBNL1-AS1/miR-135a-5p/phlpp2/foxo1 signaling pathway [31, 32]. Here, PHLPP2 is linked to urinary bladder cancer.